You just read:

JHL Biotech Submits Clinical Trial Application in Europe for Proposed Dornase Alfa Biosimilar to Affordably Manage Symptoms of Cystic Fibrosis

News provided by

JHL Biotech

Dec 20, 2017, 12:29 EST